NCT06551597 The Effect of Extremely Low-Frequency Magnetic Field on Stroke Patients
| NCT ID | NCT06551597 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Poznan University of Medical Sciences |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2024-06-01 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A stroke can cause neurological deficits resulting in decreased motor, sensory, and cognitive function, as well as a decline in psychosocial functioning. Early rehabilitation following a stroke incident is of great importance, and interventions should aim for an overall improvement in patient functioning and achieving the highest possible level of independence. In recent years, there has been an emphasis on the need to regulate the inflammation that occurs after a stroke, as it may influence the improvement or deterioration of the patient's condition. Initial studies have also indicated the potential for influencing post-stroke inflammation through physical therapy procedures. In studies on the impact of magnetotherapy on inflammatory processes in post-stroke patients, magnetotherapy is usually applied to the pelvic girdle or the head area. However, the effectiveness of these two application methods has not yet been compared. In this study, investigators aim to compare the effects of magnetotherapy applied to different body areas as a complement to neurological rehabilitation. The study aims to assess the impact of magnetotherapy as a complement to neurological rehabilitation on physical fitness and inflammatory markers in post-stroke patients, to evaluate the effect of magnetotherapy as a supplement to neurological rehabilitation on physical fitness and oxidative stress markers in post-stroke patients, and to assess the differences between the effects of magnetotherapy applied to the pelvic area versus magnetotherapy applied to the head area. The participants will be divided into three groups: one will serve as the control group, while the other two will receive magnetotherapy to the head or the pelvis, respectively, as an addition to standard neurological therapy.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 60 years * Ischemic stroke within a maximum of two weeks prior to admission to the ward Exclusion Criteria: * Severe functional impairment (FIM score \< 37) * History of previous strokes * Other neurological diseases or other conditions that could significantly impair the patient's functioning * Contraindications to magnetotherapy * Inability to establish logical verbal communication with the patient * Lack of informed consent to participate in the study
Contact & Investigator
Katarzyna Hojan, Assoc Prof
STUDY DIRECTOR
Poznan University of Medical Sciences
Frequently Asked Questions
Who can join the NCT06551597 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06551597 currently recruiting?
Yes, NCT06551597 is actively recruiting participants. Contact the research team at ttrzmiel@ump.edu.pl for enrollment information.
Where is the NCT06551597 trial being conducted?
This trial is being conducted at Poznan, Poland.
Who is sponsoring the NCT06551597 clinical trial?
NCT06551597 is sponsored by Poznan University of Medical Sciences. The principal investigator is Katarzyna Hojan, Assoc Prof at Poznan University of Medical Sciences. The trial plans to enroll 210 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.